ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

OVID Ovid Therapeutics Inc

3.10
0.11 (3.68%)
27 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Ovid Therapeutics Inc OVID 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.11 3.68% 3.10 13:00:10
개장가 저가 고가 종가 전일 종가
2.99 2.99 3.13 3.10 2.99
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
04/04/202421:00GLOBEOvid Therapeutics to Present at the 23rd Annual Needham..
08/03/202422:24EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
08/03/202422:20EDGAR2Form 8-K - Current report
08/03/202422:00GLOBEOvid Therapeutics Reports Business Updates, Fourth Quarter..
28/02/202422:00GLOBEOvid Therapeutics to Present at the TD Cowen 44th Annual..
27/02/202408:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/02/202408:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/02/202408:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/02/202407:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/02/202407:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202401:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/02/202420:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/02/202422:00GLOBEOvid Therapeutics to Present at the Oppenheimer 34th Annual..
07/12/202307:08EDGAR2Form 8-K - Current report
01/12/202321:30GLOBEOvid Therapeutics to Present Five Abstracts Supporting its..
16/11/202314:15EDGAR2Form EFFECT - Notice of Effectiveness
16/11/202306:11EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
04/11/202305:08EDGAR2Form S-3 - Registration statement under Securities Act of..
03/11/202321:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202321:10EDGAR2Form 8-K - Current report
03/11/202321:00GLOBEOvid Therapeutics Reports Third Quarter 2023 Financial..
18/10/202321:04EDGAR2Form 8-K - Current report
18/10/202321:00GLOBEOvid Therapeutics and Ligand Pharmaceuticals Enter into a..
10/10/202321:00GLOBEOvid Therapeutics to Present at the Jefferies Biotech..
03/10/202301:15EDGAR2Form 8-K - Current report
26/09/202320:30GLOBEOvid Therapeutics to Host Investor Event - R&D Day on..
20/09/202320:30GLOBEOvid Therapeutics to Present at the 2023 Cantor Fitzgerald..
30/08/202321:00GLOBEOvid Therapeutics to Participate in Upcoming September..
04/08/202322:23EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/08/202322:10EDGAR2Form 8-K - Current report
04/08/202321:00GLOBEOvid Therapeutics Reports Second Quarter 2023 Financial..
01/08/202321:00GLOBEOvid Therapeutics to Present at the BTIG Virtual..
01/08/202306:21EDGAR2Form SC 13G - Statement of acquisition of beneficial..
28/06/202321:00GLOBEOvid Therapeutics Expands Its Scientific Leadership Team &..
26/06/202321:00GLOBEOvid Therapeutics Added to Russell 3000® Index
05/05/202320:30GLOBEOvid Therapeutics Reports First Quarter 2023 Financial..
01/05/202319:00GLOBEOvid Therapeutics Announces Collaboration with Graviton..

최근 히스토리

Delayed Upgrade Clock